BRCA2 and ovarian cancer: Recent Danish papers on the distribution of gene variants in a 2006–08 cohort of patients with a suspected hereditary predisposition to breast and/or ovarian cancer found that 28% of the highly selected cohort had a pathogenic BRCA1 or BRCA2 variant [8,9,31].